- Home
- MLYS vs WTTR Comparison
MLYS vs WTTR Comparison
Compare MLYS & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- WTTR
- Stock Information
- Founded
- MLYS 2019
- WTTR 2016
- Country
- MLYS United States
- WTTR United States
- Employees
- MLYS N/A
- WTTR N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- WTTR Oilfield Services/Equipment
- Sector
- MLYS Health Care
- WTTR Energy
- Exchange
- MLYS Nasdaq
- WTTR Nasdaq
- Market Cap
- MLYS 890.6M
- WTTR 922.1M
- IPO Year
- MLYS 2023
- WTTR 2017
- Fundamental
- Price
- MLYS $37.16
- WTTR $9.09
- Analyst Decision
- MLYS Strong Buy
- WTTR Strong Buy
- Analyst Count
- MLYS 6
- WTTR 3
- Target Price
- MLYS $42.60
- WTTR $15.00
- AVG Volume (30 Days)
- MLYS 2.6M
- WTTR 984.5K
- Earning Date
- MLYS 11-10-2025
- WTTR 11-04-2025
- Dividend Yield
- MLYS N/A
- WTTR 3.08%
- EPS Growth
- MLYS N/A
- WTTR N/A
- EPS
- MLYS N/A
- WTTR 0.32
- Revenue
- MLYS N/A
- WTTR $1,458,995,000.00
- Revenue This Year
- MLYS N/A
- WTTR N/A
- Revenue Next Year
- MLYS N/A
- WTTR $0.71
- P/E Ratio
- MLYS N/A
- WTTR $28.18
- Revenue Growth
- MLYS N/A
- WTTR N/A
- 52 Week Low
- MLYS $8.24
- WTTR $7.20
- 52 Week High
- MLYS $39.20
- WTTR $15.14
- Technical
- Relative Strength Index (RSI)
- MLYS 86.84
- WTTR 60.05
- Support Level
- MLYS $35.00
- WTTR $8.23
- Resistance Level
- MLYS $15.79
- WTTR $8.73
- Average True Range (ATR)
- MLYS 2.50
- WTTR 0.32
- MACD
- MLYS 2.05
- WTTR 0.10
- Stochastic Oscillator
- MLYS 91.73
- WTTR 93.21
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.